Filtros : "Indexado na Base de dados Scopus" "Fortes, Zuleica Bruno" Removido: "1933" Limpar

Filtros



Refine with date range


  • Source: Cardiovascular Research. Unidades: ICB, FMRP

    Assunto: FARMACOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      LIMA, Victor Vitorino et al. O-GlcNAcylation contributes to the vascular effects of ET-1 via activation of the RhoA/Rho-kinase pathway. Cardiovascular Research, v. 89, n. 3, p. 614-622, 2011Tradução . . Disponível em: https://doi.org/10.1093/cvr/cvq338. Acesso em: 13 out. 2024.
    • APA

      Lima, V. V., Giachini, F. R. C., Carneiro, F. S., Carvalho, M. H. C. de, Fortes, Z. B., Webb, R. C., & Tostes, R. C. (2011). O-GlcNAcylation contributes to the vascular effects of ET-1 via activation of the RhoA/Rho-kinase pathway. Cardiovascular Research, 89( 3), 614-622. doi:10.1093/cvr/cvq338
    • NLM

      Lima VV, Giachini FRC, Carneiro FS, Carvalho MHC de, Fortes ZB, Webb RC, Tostes RC. O-GlcNAcylation contributes to the vascular effects of ET-1 via activation of the RhoA/Rho-kinase pathway [Internet]. Cardiovascular Research. 2011 ; 89( 3): 614-622.[citado 2024 out. 13 ] Available from: https://doi.org/10.1093/cvr/cvq338
    • Vancouver

      Lima VV, Giachini FRC, Carneiro FS, Carvalho MHC de, Fortes ZB, Webb RC, Tostes RC. O-GlcNAcylation contributes to the vascular effects of ET-1 via activation of the RhoA/Rho-kinase pathway [Internet]. Cardiovascular Research. 2011 ; 89( 3): 614-622.[citado 2024 out. 13 ] Available from: https://doi.org/10.1093/cvr/cvq338
  • Source: Life Sciences. Unidade: ICB

    Subjects: FARMACOLOGIA, HISTOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      FONSECA, Eveline Aparecida Isquierdo et al. Metformin reduces the stimulatory effect of obesity on in vivo Walker-256 tumor development and increases the area of tumor necrosis. Life Sciences, v. 88, n. 19-20, p. 846-852, 2011Tradução . . Disponível em: https://doi.org/10.1016/j.lfs.2011.03.005. Acesso em: 13 out. 2024.
    • APA

      Fonseca, E. A. I., Oliveira, M. A. de, Lobato, N. de S., Akamine, E. H., Colquhoun, A., Carvalho, M. H. C. de, et al. (2011). Metformin reduces the stimulatory effect of obesity on in vivo Walker-256 tumor development and increases the area of tumor necrosis. Life Sciences, 88( 19-20), 846-852. doi:10.1016/j.lfs.2011.03.005
    • NLM

      Fonseca EAI, Oliveira MA de, Lobato N de S, Akamine EH, Colquhoun A, Carvalho MHC de, Zyngier SB, Fortes ZB. Metformin reduces the stimulatory effect of obesity on in vivo Walker-256 tumor development and increases the area of tumor necrosis [Internet]. Life Sciences. 2011 ; 88( 19-20): 846-852.[citado 2024 out. 13 ] Available from: https://doi.org/10.1016/j.lfs.2011.03.005
    • Vancouver

      Fonseca EAI, Oliveira MA de, Lobato N de S, Akamine EH, Colquhoun A, Carvalho MHC de, Zyngier SB, Fortes ZB. Metformin reduces the stimulatory effect of obesity on in vivo Walker-256 tumor development and increases the area of tumor necrosis [Internet]. Life Sciences. 2011 ; 88( 19-20): 846-852.[citado 2024 out. 13 ] Available from: https://doi.org/10.1016/j.lfs.2011.03.005
  • Source: Histology and Histopathology. Unidades: ICB, FMRP

    Subjects: HISTOLOGIA, FARMACOLOGIA

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ZORN, Telma Maria Tenório et al. Maternal diabetes affects cell proliferation in developing rat placenta. Histology and Histopathology, v. 26, n. 8, p. 1049-1056, 2011Tradução . . Acesso em: 13 out. 2024.
    • APA

      Zorn, T. M. T., Zúñiga, M., Madrid, E., Tostes, R. de C. A., Fortes, Z. B., Giachini, F. R. C., & San Martín, S. (2011). Maternal diabetes affects cell proliferation in developing rat placenta. Histology and Histopathology, 26( 8), 1049-1056.
    • NLM

      Zorn TMT, Zúñiga M, Madrid E, Tostes R de CA, Fortes ZB, Giachini FRC, San Martín S. Maternal diabetes affects cell proliferation in developing rat placenta. Histology and Histopathology. 2011 ; 26( 8): 1049-1056.[citado 2024 out. 13 ]
    • Vancouver

      Zorn TMT, Zúñiga M, Madrid E, Tostes R de CA, Fortes ZB, Giachini FRC, San Martín S. Maternal diabetes affects cell proliferation in developing rat placenta. Histology and Histopathology. 2011 ; 26( 8): 1049-1056.[citado 2024 out. 13 ]
  • Source: Life Sciences. Unidade: ICB

    Assunto: FARMACOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      FRANCO, Maria do Carmo et al. Micronutrient prenatal supplementation prevents the development of hypertension and vascular endothelial damage induced by intrauterine malnutrition. Life Sciences, v. 85, n. 7/8, p. 327-333, 2009Tradução . . Disponível em: https://doi.org/10.1016/j.lfs.2009.06.013. Acesso em: 13 out. 2024.
    • APA

      Franco, M. do C., Ponzio, B. F., Gomes, G. N., Gil, F. Z., Passaglia, R. de C. A. T., Carvalho, M. H. C. de, & Fortes, Z. B. (2009). Micronutrient prenatal supplementation prevents the development of hypertension and vascular endothelial damage induced by intrauterine malnutrition. Life Sciences, 85( 7/8), 327-333. doi:10.1016/j.lfs.2009.06.013
    • NLM

      Franco M do C, Ponzio BF, Gomes GN, Gil FZ, Passaglia R de CAT, Carvalho MHC de, Fortes ZB. Micronutrient prenatal supplementation prevents the development of hypertension and vascular endothelial damage induced by intrauterine malnutrition [Internet]. Life Sciences. 2009 ; 85( 7/8): 327-333.[citado 2024 out. 13 ] Available from: https://doi.org/10.1016/j.lfs.2009.06.013
    • Vancouver

      Franco M do C, Ponzio BF, Gomes GN, Gil FZ, Passaglia R de CAT, Carvalho MHC de, Fortes ZB. Micronutrient prenatal supplementation prevents the development of hypertension and vascular endothelial damage induced by intrauterine malnutrition [Internet]. Life Sciences. 2009 ; 85( 7/8): 327-333.[citado 2024 out. 13 ] Available from: https://doi.org/10.1016/j.lfs.2009.06.013
  • Source: Inflammation Research. Unidade: ICB

    Assunto: FARMACOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SARTORETTO, J. L. et al. Chlorpropamide treatment restores the reduced carrageenaninduced paw edema and pleural exudate volume in diabetic rats. Inflammation Research, v. 57, n. 9, p. 438-443, 2008Tradução . . Disponível em: https://doi.org/10.1007/s00011-008-7211-x. Acesso em: 13 out. 2024.
    • APA

      Sartoretto, J. L., Melo, G. A., Bersani-Amado, C. A., Oliveira, M. A., Santos, R. A., Passaglia, R. de C. A. T., et al. (2008). Chlorpropamide treatment restores the reduced carrageenaninduced paw edema and pleural exudate volume in diabetic rats. Inflammation Research, 57( 9), 438-443. doi:10.1007/s00011-008-7211-x
    • NLM

      Sartoretto JL, Melo GA, Bersani-Amado CA, Oliveira MA, Santos RA, Passaglia R de CAT, Nigro D, Cuman RKN, Carvalho MHC de, Fortes ZB. Chlorpropamide treatment restores the reduced carrageenaninduced paw edema and pleural exudate volume in diabetic rats [Internet]. Inflammation Research. 2008 ; 57( 9): 438-443.[citado 2024 out. 13 ] Available from: https://doi.org/10.1007/s00011-008-7211-x
    • Vancouver

      Sartoretto JL, Melo GA, Bersani-Amado CA, Oliveira MA, Santos RA, Passaglia R de CAT, Nigro D, Cuman RKN, Carvalho MHC de, Fortes ZB. Chlorpropamide treatment restores the reduced carrageenaninduced paw edema and pleural exudate volume in diabetic rats [Internet]. Inflammation Research. 2008 ; 57( 9): 438-443.[citado 2024 out. 13 ] Available from: https://doi.org/10.1007/s00011-008-7211-x
  • Source: Peptides. Unidade: ICB

    Assunto: FARMACOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      RASTELLI, Viviani Milan Ferreira et al. Enalapril treatment corrects the reduced response to bradykinin in diabetes increasing the B2 protein expression. Peptides, v. 29, n. 3, p. 404-411, 2008Tradução . . Disponível em: https://doi.org/10.1016/j.peptides.2007.11.022. Acesso em: 13 out. 2024.
    • APA

      Rastelli, V. M. F., Oliveira, M. A., Santos, R. dos, Passaglia, R. de C. A. T., Nigro, D., Carvalho, M. H. C. de, & Fortes, Z. B. (2008). Enalapril treatment corrects the reduced response to bradykinin in diabetes increasing the B2 protein expression. Peptides, 29( 3), 404-411. doi:10.1016/j.peptides.2007.11.022
    • NLM

      Rastelli VMF, Oliveira MA, Santos R dos, Passaglia R de CAT, Nigro D, Carvalho MHC de, Fortes ZB. Enalapril treatment corrects the reduced response to bradykinin in diabetes increasing the B2 protein expression [Internet]. Peptides. 2008 ; 29( 3): 404-411.[citado 2024 out. 13 ] Available from: https://doi.org/10.1016/j.peptides.2007.11.022
    • Vancouver

      Rastelli VMF, Oliveira MA, Santos R dos, Passaglia R de CAT, Nigro D, Carvalho MHC de, Fortes ZB. Enalapril treatment corrects the reduced response to bradykinin in diabetes increasing the B2 protein expression [Internet]. Peptides. 2008 ; 29( 3): 404-411.[citado 2024 out. 13 ] Available from: https://doi.org/10.1016/j.peptides.2007.11.022
  • Source: Peptides. Unidade: ICB

    Assunto: FARMACOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      RASTELLI, Viviani Milan Ferreira et al. Lack of potentiation of bradykinin by angiotensin-(1-7) in a type 2 diabetes model: role of insulin. Peptides, v. 28, n. 5, p. 1040-1049, 2007Tradução . . Disponível em: https://doi.org/10.1016/j.peptides.2007.02.006. Acesso em: 13 out. 2024.
    • APA

      Rastelli, V. M. F., Oliveira, M. A., Santos, R. dos, Passaglia, R. de C. A. T., Nigro, D., Carvalho, M. H. C. de, & Fortes, Z. B. (2007). Lack of potentiation of bradykinin by angiotensin-(1-7) in a type 2 diabetes model: role of insulin. Peptides, 28( 5), 1040-1049. doi:10.1016/j.peptides.2007.02.006
    • NLM

      Rastelli VMF, Oliveira MA, Santos R dos, Passaglia R de CAT, Nigro D, Carvalho MHC de, Fortes ZB. Lack of potentiation of bradykinin by angiotensin-(1-7) in a type 2 diabetes model: role of insulin [Internet]. Peptides. 2007 ; 28( 5): 1040-1049.[citado 2024 out. 13 ] Available from: https://doi.org/10.1016/j.peptides.2007.02.006
    • Vancouver

      Rastelli VMF, Oliveira MA, Santos R dos, Passaglia R de CAT, Nigro D, Carvalho MHC de, Fortes ZB. Lack of potentiation of bradykinin by angiotensin-(1-7) in a type 2 diabetes model: role of insulin [Internet]. Peptides. 2007 ; 28( 5): 1040-1049.[citado 2024 out. 13 ] Available from: https://doi.org/10.1016/j.peptides.2007.02.006

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024